Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases

JCO Precis Oncol. 2020 Oct 30:4:PO.20.00096. doi: 10.1200/PO.20.00096. eCollection 2020.
No abstract available

Publication types

  • Case Reports